Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00324597
What this trial is testing

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+1 more
Jonsson Comprehensive Cancer Center 18
Early research (Phase 1)Study completedNCT02383368
What this trial is testing

A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma

Who this might be right for
LymphomaRefractory Solid TumorsAdvanced Cancer
Astellas Pharma Global Development, Inc. 39
Early research (Phase 1)Ended earlyNCT00363610
What this trial is testing

A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma

Who this might be right for
TumorsLymphoma
Enzon Pharmaceuticals, Inc. 19
Testing effectiveness (Phase 2)Looking for participantsNCT05384626
What this trial is testing

Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Nuvalent Inc. 840
Early research (Phase 1)Study completedNCT01512758
What this trial is testing

Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphomas
Millennium Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT01602289
What this trial is testing

LY2875358 in Japanese Participants With Advanced Cancer

Who this might be right for
Solid TumorsLymphomaCarcinoma, Non-Small-Cell Lung
Eli Lilly and Company 17
Not applicableUnknownNCT03822988
What this trial is testing

ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS

Who this might be right for
Advance DirectivesOncologySkin Cancer+4 more
Central Hospital, Nancy, France 150
Testing effectiveness (Phase 2)UnknownNCT02844881
What this trial is testing

Study of Apatinib and MASCT in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsExcluding T Cell Lymphoma
The First People's Hospital of Lianyungang 60
Early research (Phase 1)Study completedNCT00871663
What this trial is testing

Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)

Who this might be right for
Solid TumorsLymphoma, Non-HodgkinMultiple Myeloma+1 more
Merck Sharp & Dohme LLC 123
Testing effectiveness (Phase 2)Active Not RecruitingNCT06360575
What this trial is testing

Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Exon 14 Deletion Genetic Changes (MATCH - Subprotocol C2)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Early research (Phase 1)UnknownNCT03852823
What this trial is testing

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours

Who this might be right for
Advanced Solid TumoursCervical CancerMalignant Mesothelioma+2 more
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 192
Early research (Phase 1)Study completedNCT01800630
What this trial is testing

Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas

Who this might be right for
Advanced Solid MalignanciesMalignant Lymphomas
InnoPharmax Inc. 37
Testing effectiveness (Phase 2)Ended earlyNCT02465528
What this trial is testing

Ceritinib Rare Indications Study in ALK+ Tumors

Who this might be right for
Tumors With Aberrations in ALKAnaplastic Large Cell LymphomaInflammatory Myofibroblastic Tumor+1 more
Novartis Pharmaceuticals 22
Early research (Phase 1)Study completedNCT01877382
What this trial is testing

A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorLymphoma
Daiichi Sankyo 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565417
What this trial is testing

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Non Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaTriple Negative Breast Cancer+9 more
Immunitas Therapeutics 67
Early research (Phase 1)Study completedNCT01051635
What this trial is testing

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT01177397
What this trial is testing

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Multiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more
Celgene 226
Early research (Phase 1)Study completedNCT00553189
What this trial is testing

Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas

Who this might be right for
Solid TumorsLymphomas
National Cancer Institute (NCI) 31
Early research (Phase 1)Study completedNCT00978523
What this trial is testing

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Solid TumorsLymphoma
Arno Therapeutics 35
Next Page